Practical Applications Module 3: Outbreak Risk and Response
Details
Description
Join Us for a Virtual Conference provided in collaboration by:
The MidAtlantic AETC, The Danya Institute , the STD/HIV Prevention Training Center, and the Mid-Atlantic Regional Public Health Training Center (MAR-PHTC).
This conference will focus on the integration efforts that support practical applications of comprehensive screening. Professionals working in these areas will be able to increase their knowledge of logistics updates in an interprofessional environment. These case-based logistical updates are designed to assist in creating comprehensive screening protocols in primary care, substance use treatment, and infectious disease and sexual health clinics.
Please contact the MidAtlantic AETC at maaetc@pitt.edu or at 412-624-1895 with questions or concerns.
Agenda
|
MODULE 3 AGENDA |
|
|
8:30am-8:45am |
Sign In and Technical Assistance |
|
8:45am-9:00am |
Welcome and Introduction |
|
9:00am-10:00am 60 minutes |
Speaker Presentations Infectious Disease Outbreak: Risk and Response Re-Emergence of Stimulants/Methamphetamines: Impact on Disease Risk and Transmission |
|
10:00am-10:25am 25 minutes |
Q&A Session with Speakers Short Break |
|
10:25am-11:10am 45 minutes |
Case Study Activity |
|
11:10am-11:25am 15 minutes |
Report Out from Case Study Discussions |
|
11:25am-11:30am 5 minutes |
EVALUATION AND CONCLUDING REMARKS |
Intended Audience
Physicians, physicians assistants, nurses, nurse practitioners, case managers, social workers, students of health professions, and other members of the healthcare team. Professionals and students in infectious disease, sexual health and family planning, substance use, behavioral health, mental health, and primary care are welcome and encouraged to attend.
Accreditation
Accreditation information will be available at a later date. Please contact Marilyn Blasingame for more information at mab392@pitt.edu or 412-624-6585
Materials
Topics
A variety of the listed topics will be discussed at this event.
- Harm Reduction/Safe Injection
- Post-exposure Prophylaxis (PEP, occupational and non-occupational)
- Pre-exposure prophylaxis (PrEP)
- HIV diagnosis (i.e. HIV testing)
- Linkage to Care
- Retention and/or re-engagement in care
- Medication-assisted therapy for substance use disorders (i.e. buprenorphine, methadone, and/or naltrexone)
- Mental health disorders
- Primary care screenings
- Reproductive health, including preconception planning
- Sexually transmitted infections
- Substance use disorders
- Opioid use disorder
- Quality Improvement
- Telehealth